Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, moraxella catarrhalis, and streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results
- 1 April 1999
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 33 (4) , 275-282
- https://doi.org/10.1016/s0732-8893(98)00157-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effect of Dirithromycin onHaemophilus influenzaeInfection of the Respiratory MucosaAntimicrobial Agents and Chemotherapy, 1998
- A Five-Day Course of Dirithromycin in the Treatment of Acute Exacerbation of Severe Chronic Obstructive Pulmonary DiseaseJournal of Chemotherapy, 1997
- Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative studyJournal of Antimicrobial Chemotherapy, 1996
- Tissue distribution of dirithromycin: Comparison with erythromycinJournal of Antimicrobial Chemotherapy, 1993
- In-vitro activity of dirithromycin in comparison with other new and established macrolidesJournal of Antimicrobial Chemotherapy, 1993
- Dirithromycin disc susceptibility tests: interpretative criteria and quality control parametersJournal of Antimicrobial Chemotherapy, 1993
- A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitisJournal of Antimicrobial Chemotherapy, 1993
- Clinical efficacy of dirithromycin in pneumoniaJournal of Antimicrobial Chemotherapy, 1993
- Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycinAntimicrobial Agents and Chemotherapy, 1991
- In vitro activity of dirithromycin (LY 237216) compared with activities of other macrolide antibioticsAntimicrobial Agents and Chemotherapy, 1990